repression of transcriptional programs involved in activation, proliferation, and cytokine production, and these effects primarily contribute to the immune-suppressive effect of CsA. 8, 9 However, recent research has highlighted that structural cells of the kidneys, including epithelial cells and fibroblasts, are also major targets of CsA, and that the effect of CsA on these cells may be the primary contributor to nephrotoxicity and fibrosis, which subsequently culminate in the clinical vignette of CNT. [10] [11] [12] [13] Therefore, understanding how CsA modulates the activities of epithelial cells or fibroblasts may lead to ways to reduce CNT.
TWEAK (TNF-related weak inducer of apoptosis) (TNFSF12) is a member of the tumor necrosis factor superfamily (TNFSF) that is thought to be involved in chronic inflammation and fibrosis of various organs, including the kidneys. [14] [15] [16] [17] We and others have recently demonstrated that administration of recombinant TWEAK (rTWEAK) to mice is sufficient to induce inflammation and fibrosis, [18] [19] [20] and animals deficient in TWEAK or treated with TWEAK-neutralizing antibodies are significantly protected from diseases displaying chronic inflammation and fibrosis. 19, [21] [22] [23] [24] TWEAK is produced by a number of cell types, notably resident and infiltrating myeloid cells, including neutrophils and inflammatory monocytes. It engages its receptor Fn14 (TNFRSF12A) on target cells to initiate its pro-inflammatory and pro-fibrotic activities. 15, 25, 26 Importantly, Fn14 has a low ubiquitous expression on most cell types including epithelial cells. However, its expression is rapidly induced by stimuli associated with stress, and this upregulation represents one of the main regulatory determinants for the contribution of TWEAK to an inflammatory response. 15 In the present study, we show that the TWEAK/Fn14 pathway is indispensable in experimental CNT. We further identify tubular epithelial cells of the kidney as a major target of CsA activity, in that Fn14 is strongly upregulated by exposure to CsA, leading to sensitization of epithelial cells towards the pro-inflammatory activities of TWEAK.
| MATERIALS AND METHODS

| Mice, recombinant proteins, and reagents
Age-and sex-matched wild-type and TWEAK-deficient animals on the C57BL/6 background were used for the experiments. 18 All animals were maintained in an Specific Pathogen Free environment. All experiments were in compliance with the regulations of the La Jolla Institute 
| Animal model for acute CNT
Acute CNT lesions were induced as previously described. 10 Briefly, mice were kept on a salt-reduced diet during the experiments. 
| Histology
Specimens from recovered organs were fixed in 4% Zinc-Buffered Formalin (Sigma Aldrich) and embedded in paraffin blocks. Sections (4 μm thick) were generated and stained with general protocols for periodic acid-Schiff staining. CNT lesions were evaluated using a semiquantitative score (cumulative score of 0-4 for the following criteria: tubular epithelial swelling, loss of brush border, vacuolar degeneration, necrotic tubules, and cast formation). 40 Ten High
Power Fields from the cortex and medullary regions were quantified by 2 independent and blinded observers (D.S., R.H.) and averaged. Immunofluorescence staining for Fn14 was performed on formalin-fixed and paraffin-embedded tissues using an AF647- and 4′,6-diamidino-2-phenylindole counterstaining. Isotype controls were run in parallel. Histology sections were acquired using a Zeiss AxioScan Z1 slide scanner (Zeiss, Dublin, CA) and images were analyzed using Zen2 software and representative samples are presented.
| Flow cytometry analysis of kidney-infiltrating cells
Kidney specimens were digested and stained for cellular infiltrates.
Specifically, kidneys were digested with 2 mg/mL Collagenase IV 
| In vitro experiments
The murine kidney epithelial cell line MCT has been described previously 41 and was kindly provided by Dr. Raymond Harris (Vanderbilt University, Nashville, TN). The human kidney epithelial cell line HK-2 was from AddexBio (San Diego, CA 
| Protein isolation and immunoblot analysis
Western blot analysis was performed from complete cell lysates under denaturating conditions. Briefly, cells were washed and lysed in com- 
| RNA isolation, reverse transcription, and quantitative polymerase chain reaction
Total RNA was isolated from skin biopsies using TRIzol reagent (Invitrogen, Carlsbad, CA). cDNA was generated using HighCapacity RT Kit (Applied Biosystems, Carlsbad, CA). Real-time polymerase chain reaction was performed using SYBR Green intercalation (LIGHT cycler 480 DNA SYRB Green I master mix;
Roche, Pleasanton, CA) and expression calculated using the deltaCT method relative to the housekeeping gene GAPDH. The 
| Gene set enrichment analysis
GenePattern 2.0 42 was used to process RNA array data for gene set enrichment analysis, 43 which was run with the default settings (100 iterations, weighted). Gene enrichment was tested on rat kidney gene array datasets of animals treated with vehicle control (n = 8, animals
GSM480738-41 and GSM480746-49) or 25 mg/kg per day CsA (n = 9, animals GSM480765-69 and GSM480775-78) for 14-28 days (accession number Array Express GSE19366). 37 A predefined set reflecting genes reported in the literature to associate with the TWEAK/ Fn14 signaling pathway (Table S1 ) was tested. A False Discovery Rate P value <.05 was considered statistically significant.
| Statistical analysis
Statistical analysis was performed using Prism5 software (GraphPad,
San Diego, CA). Groups were analyzed by t test or Mann-Whitney
U test where indicated. A P value <.05 was considered statistically significant (*).
| RESULTS
| TWEAK deficiency protects from acute CNT
We first assessed the requirement for the TWEAK/Fn14 pathway in the pathogenesis of CNT by testing animals sufficient or deficient for the TWEAK gene. Inbred mice are naturally resistant to chronic CNT lesions, 27 but elicit signs of acute nephrotoxicity upon short-term exposure with CNIs, including CsA. 10 Indeed, wild-type (WT) animals developed kidney disease with characteristic features of acute CNT, including loss of epithelial brush border, tubular epithelial vacuolization, and epithelial desquamation ( Figure 1A, B) . In contrast, TWEAK-deficient animals had strikingly reduced disease activity in respect to tubulotoxicity when analyzed by histologic scoring for the same end points. Furthermore, CsA treatment strongly increased serum creatinine levels at day 3 of the experiment in both wild-type and TWEAK-deficient animals, yet relative increase was significantly reduced in the latter group ( Figure 1C) . Correlating with this, transcript levels of TWEAK were found to be significantly induced in kidneys from WT animals treated with CsA ( Figure 1D ). 
| CsA strongly induces Fn14 in renal tubular epithelial cells in vivo and in vitro
The receptor of TWEAK, Fn14, is expressed at low constitutive levels in many cell types and most tissues, including the kidneys. In mouse models of ischemia/reperfusion, glomerulonephritis, or ureter ligation, this receptor is rapidly upregulated in the kidney parenchyma. We therefore sought to determine the expression levels of 
| CsA sensitizes renal tubular epithelial cells to rTWEAK in vitro
We and others have described TWEAK as a potent inducer of proinflammatory and pro-fibrotic genes in epithelial cells. Transforming growth factor beta (TGFβ) has been critically implicated in the pathogenesis of kidney fibrosis (reviewed in [30] ).
Intriguingly, many nephrotoxic stimuli such as advanced glycation endproduct and angiotensin II converge at the level of TGFβ since they induce the production and release of this factor, which then drives and maintains fibrotic kidney responses. 31, 32 Furthermore, TGFβ has been identified as an effector molecule in CNT, since knockout of signaling components of the TGFβ pathway, or neutralizing this factor, protects from CsA nephrotoxic activity. [33] [34] [35] In a recent publication,
Chen et al proposed that TGFβ can induce Fn14 expression in der-
mal fibroblasts under some conditions, which could then contribute to fibrotic responses. 36 We therefore sought to determine whether the Fn14-inducing activity of CsA was driven indirectly via the induction 
| CsA and TWEAK cooperate in their nephrotoxic capacity in vivo
To further investigate the activity of CsA and TWEAK, we analyzed the nephrotoxic effects of either CsA, rTWEAK, or combined treatments in vivo. We and others have shown that rTWEAK is sufficient to drive inflammation and fibrosis in various tissues, including the kidneys. While injection of either substance alone resulted in moderate tubulotoxicity, the combined treatment elicited stronger disease activity ( Figure 4A, B) . Furthermore, cellular infiltrates were greatly enhanced in animals receiving combined treatment ( Figure 4C ). These findings strongly support our in vitro experiments where CsA and TWEAK elicited cooperative proinflammatory activities.
| The TWEAK/Fn14 pathway is enriched in chronic CNT lesions
To substantiate a potential role of the TWEAK/Fn14 signaling axis in chronic CNT, we analyzed gene arrays from CsA-treated rats. 37 Intriguingly, signature genes of the TWEAK/Fn14 pathway were highly enriched among the induced transcripts in animals exposed to
CsA for 14 days, and enrichment further extended to a protocol with a 28-day treatment ( Figure 4A , B). Fn14 (TNFRSF12A) was highly induced in all CsA-exposed animals when compared to vehicle-treated individuals. This analysis identified Fn14 (TNFRSF12A) as one of the highest induced transcripts (17 th highest ranked gene out of 13 355
genes, data not shown). These findings suggest that the TWEAK/ Fn14 axis is critical and instrumental in the pathogenesis of acute and chronic CNT. 
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